CompletedNot Applicable

Patient and Colonoscopy Cleansing Quality Agreement

Spain1,011 participantsStarted 2021-02-17

Plain-language summary

The main purpose of the study is to determine the agreement between colon cleansing quality assessed by a validated scale (Boston Bowel Preparation Scale, BBPS) and the perception of the patient. Patients will be prepared with polyethylene glycol (PEG), PEG plus ascorbic acid (PEG-Asc) or sodium picosulfate-oxide magnesium solution (PS). The secondary aim is to assess predictors of poor bowel cleansing.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>18, * to sign the informed consent * patients with indication of outpatient colonoscopy * patient ingesting preparation Exclusion Criteria: * Last colonoscopy with poor bowel preparation. * Ileus, intestinal obstruction, megacolon. * Poorly controlled hypertension (systolic hypertension\> 180mmHg, dyastolic hypertension\> 100mmHg). * Terminal renal failure (pre-dialysis or dialysis). * Congestive heart failure (NYHA III-IV). * Acute liver failure. * Severe psychiatric illness. * Dementia with difficulty in the intake of the preparation. * Pregnancy or breastfeeding. * Refusal to participate in the study. * Allergies. * Not looking at the characteristics of the last stool.

What they're measuring

Quality of bowel cleansing

Timeframe: [Time frame: 1 years][Designated as safety issue: No]

Trial details

NCT IDNCT04702646

SponsorHospital Universitario de Canarias

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-05-31

View on ClinicalTrials.gov More Cleansing Quality of the Colon trials